serotonin reuptake: nootropics and compounds | sci-wiki

Sildenafil + Dapoxetine

Sildenafil plus dapoxetine is a pairing of two oral drugs used together in men who have both erectile dysfunction and premature ejaculation. Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor that improves erectile function, while dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) developed specifically to delay ejaculation. The pairing targets the two most common male sexual complaints at once, and fixed-dose tablets combining them are marketed in some countries.

1 outlet

Blend

Tadalafil + Dapoxetine

Tadalafil plus dapoxetine is a fixed-dose combination that pairs two medicines with complementary effects on male sexual function. Tadalafil is a long-acting PDE5 inhibitor that improves erections, while dapoxetine is a short-acting selective serotonin reuptake inhibitor used to delay ejaculation. Marketed under names such as Tadapox, the combination is aimed at men who have both erectile dysfunction and premature ejaculation and is taken on demand before sexual activity.

1 outlet

Blend

Vardenafil + Dapoxetine

Vardenafil plus dapoxetine is a combination of two drugs used together to treat men who have both erectile dysfunction and premature ejaculation. Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor that improves erections, while dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) that delays ejaculation. The pairing is taken on demand before sexual activity and is marketed as a fixed-dose combination in some countries.

1 outlet

Antidepressant

Venlafaxine

Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) used for major depressive disorder and several anxiety disorders, and available in immediate-release and extended-release forms. It is distinguished by an ascending dose-response relationship: at low doses it behaves much like a selective serotonin reuptake inhibitor, while progressively higher doses recruit norepinephrine reuptake inhibition, which contributes both to added efficacy and to dose-dependent increases in blood pressure. Beyond monoamine transport, preclinical work implicates sigma-1 receptor modulation in its antidepressant action, and the drug is widely repurposed as an effective nonhormonal treatment for menopausal and cancer-therapy-related hot flashes. Network meta-analyses place it among the more efficacious antidepressants, although tolerability, cardiovascular effects in overdose, and a pronounced discontinuation syndrome temper its use.

2 outlets

Modulators

Astra2959

Astra2959 is an obscure research chemical identified by vendors as N,N-dimethyl-3,3-diphenylcyclobutanamine hydrochloride, the N,N-dimethyl analog of 3,3-diphenylcyclobutanamine. The parent scaffold is a psychostimulant originally explored as an antidepressant in the late 1970s that inhibits reuptake of serotonin, norepinephrine and dopamine; the N,N-dimethyl form is reported to be the most potent locomotor stimulant of the series. Rigorous, compound-specific published data on Astra2959 itself are essentially absent.

reference